Skip to Content

  • Search

View Additional Section Content

A Phase III, Multicenter, International, Randomized, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10mg and 25 mg administered orally once daily) Compared to Usual Care in Type 2 Diabetes Mellitus Patients With Increased Cardiovascular Risk

Principal Investigator(s)
Michael Seidner, M.D.

Clinical Trial Categories

  • Diabetes
Contact
Renee Backer, CCRC at 215-361-7164
or research@greenandseidner.com

Location

  • Green and Seidner Family Practice Associates, PC
    826 North Broad Street
    Lansdale, PA 19446
    Office: 215-855-1054
    Fax: 215-855-3786

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details